A phase II study of modulated-capecitabine and docetaxel in chemonaive patients with advanced non-small cell lung cancer (NSCLC)

Erin M. Bertino, Tanios Bekaii-Saab, Soledad Fernandez, Robert B. Diasio, Nagla A. Karim, Gregory A. Otterson, Miguel A. Villalona-Calero

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II study of modulated-capecitabine and docetaxel in chemonaive patients with advanced non-small cell lung cancer (NSCLC)'. Together they form a unique fingerprint.

Medicine & Life Sciences